Bacary Ba(@bacary_ba) 's Twitter Profileg
Bacary Ba

@bacary_ba

Ancien Interne des Hôpitaux du Sénégal #Néphrologue #MASTER de Génétique humaine #UCAD_FMPO_DAKAR

ID:944996528539799552

calendar_today24-12-2017 18:21:44

1,8K Tweets

953 Followers

602 Following

JASN_News(@JASN_News) 's Twitter Profile Photo

There are many hypotheses to explain how APOL1 risk variants cause kidney disease. This Perspective discusses how the many different clinical presentations of APOL1 kidney disease suggest there could be more than one injury mechanism bit.ly/JASN0367

account_circle
ASN Kidney360(@ASNKidney360) 's Twitter Profile Photo

The effect of SGLT2 inhibitor (SGLT2i) on kidney function after AKI is unknown. This study found that SGLT2i use was linked to a lower risk for CKD progression and for recurrent AKI among those with diabetic kidney disease and recent AKI bit.ly/KID0375

The effect of SGLT2 inhibitor (SGLT2i) on kidney function after AKI is unknown. This study found that SGLT2i use was linked to a lower risk for CKD progression and for recurrent AKI among those with diabetic kidney disease and recent AKI bit.ly/KID0375
account_circle
Edgar V. Lerma 🇵🇭(@edgarvlermamd) 's Twitter Profile Photo

EMPA-KIDNEY: Among a wide range of patients w/ CKD who were at risk for disease progression, empagliflozin therapy led to a lower risk of progression of kidney disease or death from CV causes (vs. placebo) ca. 2022 from NEJM

sighting

EMPA-KIDNEY: Among a wide range of patients w/ CKD who were at risk for disease progression, empagliflozin therapy led to a lower risk of progression of kidney disease or death from CV causes (vs. placebo) ca. 2022 from @NEJM #Nephpearls #RPA24 #RPA2024 #VisualAbstract sighting
account_circle
Groupe de Recherche Interdisciplinaire Onco-Nephro(@Grifonconephro) 's Twitter Profile Photo

Si vous prescrivez du Cisplatine votre avis nous intéresse !
Par ce questionnaire, nous cherchons à évaluer les différentes pratiques d'hydratation des patients sous cisplatine haute dose (> 50 mg/m²).🎯

Répondez au questionnaire : sondageonline.fr/s/emrxxm3

Partages apprécies🔄

Si vous prescrivez du Cisplatine votre avis nous intéresse ! Par ce questionnaire, nous cherchons à évaluer les différentes pratiques d'hydratation des patients sous cisplatine haute dose (> 50 mg/m²).🎯 Répondez au questionnaire : sondageonline.fr/s/emrxxm3 Partages apprécies🔄
account_circle
Matthieu Delaye(@DelayeMatthieu) 's Twitter Profile Photo

On se retrouve le 20 juin prochain à la 4eme journée d'onconéphrologie !

C'est à Lyon ou en visio

Et c'est ouvert à tou.tes les intéressé.e.s 😀

Société Française du Cancer

account_circle
Groupe de Recherche Interdisciplinaire Onco-Nephro(@Grifonconephro) 's Twitter Profile Photo

Evaluation of a new score associated with acute kidney injury in patients treated with cisplatin based EXTREME regimen

pubmed.ncbi.nlm.nih.gov/38566065/

account_circle
Kidney Medicine(@KidneyMed) 's Twitter Profile Photo

Kidney Cysts in Children with Alport Syndrome: a Report of Three Cases

Authors highlight that kidney cysts in adolescents with suspected AS should not discourage clinicians from testing for pathogenic COL4A3–COL4A5 variants

buff.ly/3J5sSD9

Kidney Cysts in Children with Alport Syndrome: a Report of Three Cases Authors highlight that kidney cysts in adolescents with suspected AS should not discourage clinicians from testing for pathogenic COL4A3–COL4A5 variants buff.ly/3J5sSD9
account_circle
AJKD(@AJKDonline) 's Twitter Profile Photo

AJKD invites applications for its Editorial Internship Program, which will provide editorial experience to early career researchers interested in education, teaching, or medical editing/writing.

Apply by April 30 - details here: buff.ly/49gmT9z

AJKD invites applications for its Editorial Internship Program, which will provide editorial experience to early career researchers interested in education, teaching, or medical editing/writing. Apply by April 30 - details here: buff.ly/49gmT9z
account_circle
Massamba FALL(@lazanba_fall) 's Twitter Profile Photo

Aux entrepreneurs de la TL. 🇸🇳

Je suis convaincu que le Sénégal peut devenir un leader de la digitalisation en Afrique de l'Ouest.

J'ai une idée ambitieuse pour créer une entreprise nationale (privée avec la participation de l’état) de la taille d'Atos en France,

afin de

account_circle
Nature Reviews Nephrology(@NatRevNeph) 's Twitter Profile Photo

We are extremely pleased to publish this Consensus Statement from Int Society of Nephrology, ERA - European Renal Association and American Society of Nephrology, and supported by regional societies, advocating for the recognition of kidney disease as a major driver of premature mortality. World Health Organization (WHO)

go.nature.com/3U3Ll8f

We are extremely pleased to publish this Consensus Statement from @ISNkidneycare, @ERAkidney and @ASNKidney, and supported by regional societies, advocating for the recognition of kidney disease as a major #NCD driver of premature mortality. @WHO go.nature.com/3U3Ll8f
account_circle
Bentaleb sow(@SowBentaleb) 's Twitter Profile Photo

Pour finir la soirée en apothéose

4mn30 d’images qui résument la journée d’aujourd’hui, de la prestation de serment à la passation de service

À consommer sans modération

account_circle
Marco Bonilla(@Nephr0s) 's Twitter Profile Photo

Efficacy of rituximab for patients with anti-glomerular basement membrane disease academic.oup.com/ndt/article-ab… NDT

account_circle
Christian Combe(@ChristianCombe) 's Twitter Profile Photo

Telmisartan has the longest half-life, losartan was the first of its class, but can be replaced by other ARBs now!
tinyurl.com/2yq6btzd
I have no COI!

Telmisartan has the longest half-life, losartan was the first of its class, but can be replaced by other ARBs now! tinyurl.com/2yq6btzd I have no COI!
account_circle
Nikhil Shah MBBS DNB(IM, Neph)🇨🇦(@dr_nikhilshah) 's Twitter Profile Photo

📃 Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group
🔗 bit.ly/4aflZL9 @ndtsocial Hans-Joachim Anders
👤 Safak Mirioglu et al.
📽️ bit.ly/3TGf72F Author Video

📃 Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group #OpenAccess #Review #EditorsChoice 🔗 bit.ly/4aflZL9 @ndtsocial @hjanders_hans 👤 @smirioglu et al. 📽️ bit.ly/3TGf72F Author Video
account_circle